Smith Asset Management Group LP raised its position in Imperva Inc (NYSE:IMPV) by 0.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,295 shares of the software maker’s stock after buying an additional 610 shares during the period. Smith Asset Management Group LP’s holdings in Imperva were worth $3,890,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of IMPV. Fisher Asset Management LLC increased its stake in shares of Imperva by 27.1% in the first quarter. Fisher Asset Management LLC now owns 173,457 shares of the software maker’s stock worth $7,120,000 after buying an additional 37,028 shares during the last quarter. Stephens Investment Management Group LLC increased its stake in shares of Imperva by 1.7% in the first quarter. Stephens Investment Management Group LLC now owns 228,024 shares of the software maker’s stock worth $9,360,000 after buying an additional 3,894 shares during the last quarter. Retirement Systems of Alabama increased its stake in shares of Imperva by 27.6% in the first quarter. Retirement Systems of Alabama now owns 115,701 shares of the software maker’s stock worth $4,750,000 after buying an additional 25,000 shares during the last quarter. Norges Bank acquired a new stake in shares of Imperva during the fourth quarter worth $964,000. Finally, Bank of Nova Scotia acquired a new stake in shares of Imperva during the first quarter worth $7,184,000. Institutional investors and hedge funds own 92.72% of the company’s stock.

Imperva Inc (IMPV) opened at 43.60 on Friday. The stock’s market cap is $1.47 billion. Imperva Inc has a 52-week low of $34.40 and a 52-week high of $57.24. The firm has a 50-day moving average price of $47.61 and a 200 day moving average price of $45.32.

Imperva (NYSE:IMPV) last posted its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.05 by $0.15. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company had revenue of $74.44 million for the quarter, compared to the consensus estimate of $74.30 million. During the same period last year, the business earned ($0.23) EPS. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. On average, analysts forecast that Imperva Inc will post $0.81 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/08/12/imperva-inc-impv-shares-bought-by-smith-asset-management-group-lp.html.

A number of equities research analysts have commented on IMPV shares. Zacks Investment Research raised Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective for the company in a research note on Wednesday, August 2nd. Evercore ISI set a $56.00 price objective on Imperva and gave the company a “buy” rating in a research note on Friday, July 28th. BidaskClub cut Imperva from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Susquehanna Bancshares Inc started coverage on Imperva in a research note on Wednesday, June 7th. They issued a “positive” rating and a $60.00 price objective for the company. Finally, Monness Crespi & Hardt raised their price objective on Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $51.25.

In other Imperva news, insider Amichai Shulman sold 3,089 shares of the stock in a transaction on Monday, May 15th. The stock was sold at an average price of $48.70, for a total transaction of $150,434.30. Following the sale, the insider now directly owns 100,151 shares in the company, valued at approximately $4,877,353.70. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Sunil D. Nagdev sold 4,857 shares of the stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $49.00, for a total value of $237,993.00. Following the sale, the senior vice president now owns 16,290 shares in the company, valued at $798,210. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).

Institutional Ownership by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.